Synthesis of Tricolorin F
4], 4.16 (dd, J ) 7.5, 7.5, 1H) [Fuc-2], 4.31 (d, J ) 7.5, 1H)
[Fuc-1], 4.47 (d, J ) 12.0, 1H), 4.53 (brd, 2H), 4.62 (d, J )
12.0, 1H), 4.78 (d, J ) 12.0, 1H), 4.83 (d, J ) 11.0, 1H), 5.01
(d, J ) 11.0, 1H), 7.10-7.51 (m, 15H); 13C NMR (CDCl3) δ 14.5,
16.8, 23.0, 25.0, 25.3, 25.5, 26.5, 28.3, 29.3, 29.6 (x2), 29.8, 29.9,
32.1, 33.8, 34.5 (x2), 51.5 68.8, 69.0, 71.5, 72.3, 73.5, 75.0 (x2),
75.8, 76.0, 78.5, 79.0, 79.8, 84.0, 100.0, 103.8, 109.5, 127.4,
127.6, 127.7, 127.8, 128.2, 128.4, 138.1, 138.2, 138.3, 174.2;
negative-ion HRFAB-MS m/z 903.5260 [M - H] (calcd for
between quinovose H-1 (δ 5.29, d, J 1,2 ) 8.0 Hz) and H-2
(δ 5.48, dd, J 2,3 ) 9.6 Hz). Basic hydrolysis of the acetate
and methyl ester gave tricoloric acid C (11).
The critical lactonization step was achieved following
the Yamaguchi protocol, providing protected tricolorin F
(12). Removal of the acetonide and benzyl groups was
accomplished by hydrogenolysis under acidic conditions
1
to obtain synthetic tricolorin F (1) identical by H and
13C NMR with an authentic sample of the natural
product.4
C
53H75O12 903.5258).
Meth yl 11(S)-11-[[2-O-Acetyl-3,4-d i-O-ben zyl-â-D-qu in o-
vosyl)-(1f2)-(3,4,6-t r i-O-b e n zyl-â-D -glu cop yr a n osyl)-
(1f2)-3,4-O-isop r op ylid en e-â-D-fu cop yr a n osyl]oxy]h exa -
d eca n oa te (10). Compound 8 (32 mg, 0.035 mmol) and
imidate 9 (19 mg, 0.035 mmol) were coevaporated with freshly
distilled benzene. The oily residue was dissolved in 1.5 mL of
CH2Cl2, and the resulting solution was cooled to -20 °C and
then treated with ethereal BF3‚Et2O (0.25 M, 0.05 mL). The
resulting mixture was stirred for 1 h under N2, the reaction
was then quenched by the addition of saturated aqueous
NaHCO3, and the resulting mixture was extracted with
CH2Cl2. The organic phase was dried over Na2SO4 and
evaporated with a rotary evaporator. Purification by chroma-
tography, eluting with 20% EtOAc in hexanes, gave 27 mg
(60%) of 10 as a syrup: [R]D -14 (c 7.3, CH2Cl2); IR (thin film)
Exp er im en ta l Section
Gen er a l Meth od s. Unless otherwise stated, 1H and 13C
NMR spectra were recorded in CDCl3 and C5D5N solution at
400 and 125 MHz, respectively. Coupling constants (J ) are
reported in Hz. Specific rotations were measured in CH2Cl2
at rt. Reagents and solvent were used as received from
commercial suppliers. All intermediates were purified by flash
chromatography on silica gel and eluted with EtOAc in
hexanes. Reaction progress was monitored on glass silica gel
60 (E. Merck), heating after dipping in CAM solution ((NH4)6-
Mo7O24‚6H2O (5 g) and Ce(SO4)2 (100 mg) in 5% aq H2SO4 (100
mL)).
1
1747 cm-1; H NMR (C5D5N) δ 0.84 (t, J ) 7.0, 3H) [J al-16],
Met h yl (11S)-11-[[(2-O-Acet yl-3,4,6-t r i-O-b en zyl-â-D-
glu cop yr a n osyl)-(1f2)-3,4-O-isop r op ylid en e-â-D-fu cop y-
r a n osyl]oxy]h exa d eca n oa te (7). Alcohol 5 (50 mg, 0.108
mmol) and imidate 6 (68 mg, 0.108 mmol) were coevaporated
in freshly distilled benzene, and the oily residue was dissolved
in 1 mL of CH2Cl2, and cooled to -20 °C. After careful addition
of BF3‚Et2O (0.25 M in Et2O, 0.1 mL), the reaction was allowed
to proceed for 1 h. The reaction mixture was treated with a
saturated solution of NaHCO3 and the resulting mixture
extracted with CH2Cl2. The organic phase was dried over
Na2SO4, filtered, and evaporated in vacuo. Purification by
chromatography on silica gel, eluting with 20% EtOAc in
hexanes, gave 60 mg (70%) of compound 7 as an oil: [R]D -15
1.22-1.40 (m, 20H), 1.48-1.51 (m, 4H), 1.40 (s, 3H), 1.50 (d,
J ) 6.1, 3H) [Qui-6], 1.52 (d, J ) 6.5, 3H) [Fuc-6], 1.56 (s, 3H),
2.02 (s, 3H), 1.60-1.66 (m, 3H), 2.31 (t, J ) 7.5, 2H) [J al-2],
3.45 (dd, J ) 9.2, 9.2, 1H) [Qui-4], 3.61 (s, 3H), 3.66 (dq, J )
6.2, 9.3, 1H) [Qui-5], 3.73 (m, 1H) [Glu-5], 3.83-4.03 (m, 6H),
4.07 (dd, J ) 7.5, 8.0, 1H) [Glu-2], 4.22 (dd, J ) 2.0, 6.0, 1H)
[Fuc-4], 4.35 (dd, J ) 6.2, 7.1, 1H) [Fuc-3], 4.66 (d, J ) 11.3,
1H), 4.70-4.74 (m, 5H), 4.83 (d, J ) 11.3, 1H), 4.85 (d, J )
11.3, 1H), 4.96 (d, J ) 11.3, 1H), 4.98 (d, J ) 11.3, 1H), 5.04
(d, J ) 11.3, 1H), 5.14 (d, J ) 11.3, 1H), 5.29 (d, J ) 8.0, 1H)
[Qui-1], 5.40 (d, J ) 7.5, 1H) [Glu-1], 5.48 (dd, J ) 8.0, 9.6,
1H) [Qui-2], 7.14-751 (m, 25H); 13C NMR (C5D5N) δ 12.8, 15.7,
16.9, 19.5, 21.4, 23.8 (x2), 24.1, 24.9, 26.5, 27.9, 28.3, 28.5, 28.7,
29.0, 30.7, 32.6, 33.3, 33.8, 50.0, 67.2, 67.6, 70.4, 71.9, 72.9,
73.3, 73.7, 73.9, 74.0, 74.1, 75.2, 75.4, 77.4, 77.8, 78.2, 79.5,
82.2, 82.5, 83.7, 98.1, 99.4, 99.8, 108.2, 127.3, 127.5, 128.5,
138.9, 168.4, 172.4; negative-ion HRFAB-MS m/z 1271.6885
[M - H] (calcd for C75H99O17 m/z 1271.6882).
11(S)-11-[[2-O-Acetyl-3,4-d i-O-ben zyl-â-D-qu in ovosyl)-
(1f2)-(3,4,6-tr i-O-ben zyl-â-D-glu cop yr a n osyl)-(1f2)-3,4-
O-isop r op ylid en e-â-D-fu cop yr a n osyl]oxy]h exa d eca n o-
ic Acid (11). A solution of compound 10 (20 mg, 0.015 mmol)
and KOH (10 mg) in CH3OH-H2O (4 mL, 9:1 v/v) was refluxed
for 4 h. The resulting solution was dissolved in 5 mL of
CH2Cl2 and washed with 1 M HCl (1 × 5 mL), dried over
Na2SO4 and evaporated. Purification by chromatography,
eluting with 20% EtOAc in hexanes, gave 15 mg (80%) of acid
11 as a syrup: [R]D -8 (c ) 0.90, CH2Cl2); IR (CH2Cl2 solution)
3430, 1710 cm-1; 1H NMR (C5D5N) δ 0.79 (t, J ) 7.0, 3H) [J al-
16], 1.18-1.25 (m, 20H), 1.34 (s, 3H), 1.47 (d, J ) 6.5, 3H)
[Fuc-6], 1.48 (d, J ) 6.1, 3H) [Qui-6], 1.53 (s, 3H), 1.57 (m,
3H), 1.65 (m, 2H), 2.45 (t, J ) 7.5, 2H) [J al-2], 3.37 (dd, J )
9.0, 9.0, 1H) [Qui-4], 3.62 (dq, J ) 6.1, 9.0, 1H), [Qui-5], 3.70
(m, 1H) [Glu-5], 3.79 (quintet, J ) 6.0, 1H) [J al-11], 3.95-
3.80 (m, 6H), 3.99 (dd, J ) 7.7, 8.5, 1H) [Qui-2], 4.12 (dd, J )
2.0, 6.5, 1H) [Fuc-4], 4.14 (dd, J ) 7.2, 8.5, 1H) [Glu-2], 4.31
(dd, J ) 6.5, 7.5, 1H) [Fuc-3], 4.67 (d, J ) 7.5, 1H) [Fuc-1],
4.63 (d, J ) 12.0, 1H), 4.66 (d, J ) 12.0, 1H), 4.68 (d, J ) 12.0,
1H), 4.69 (dd, J ) 6.5, 7.5, 1H) [Fuc-2], 4.71 (d, J ) 11.2, 1H),
4.79 (d, J ) 11.2, 1H), 4.99 (d, J ) 10.5, 1H), 5.01 (d, J ) 10.3,
1H), 5.03 (d, J ) 11.5, 1H), 5.15 (d, J ) 7.7, 1H) [Qui-1], 5.31
(d, J ) 11.5, 1H), 5.33 (d, J ) 10.3, 1H), 5.40 (d, J ) 7.2, 1H)
[Glu-1], 6.97-7.66 (m, 25H); 13C NMR (C5D5N) δ 14.1, 17.6,
18.4, 22.5, 22.6, 24.9, 25.3, 25.6, 26.5, 27.7, 29.3, 29.6, 29.9,
29.5, 30.1, 31.9, 34.5, 34.9, 37.4, 68.3, 69.2, 71.4, 73.2, 74.4,
74.7, 74.8, 75.3, 75.8, 76.5, 76.8, 78.5, 79.5, 80.4, 83.4, 85.2,
(c 1.8, CH2Cl2); IR (thin film) 1742 cm-1; H NMR (CDCl3) δ
1
0.89 (t, J ) 7.0, 3H) [J al-16], 1.22-1.43 (m, 20H), 1.28 (s, 3H),
1.33 (d, J ) 6.5, 3H) [Fuc-6], 1.39-1.49 (m, 5H), 1.44 (s, 3H),
1.50-1.59 (m, 2H), 1.97 (s, 3H), 2.26 (t, J ) 7.5, 2H) [J al-2],
3.42 (brd, J ) 10.0, 1H) [Glu-5], 3.53 (quintet, J ) 6.0, 1H)
[J alp-11], 3.63 (s, 3H), 3.78-3.65 (m, 6H), 3.92 (dd, J ) 1.9,
5.7, 1H) [Fuc-4], 4.03 (dd, J ) 6.0, 7.0, 1H), 4.26 (d, J ) 7.0
Hz, 1H) [Fuc-1], 4.52 (d, J ) 12.0, 1H), 4.58 (d, J ) 11.0, 1H),
4.64 (d, J ) 12.0, 1H), 4.66 (d, J ) 11.0, 1H), 4.73 (d, J ) 8.0,
1H) [Gluc-1], 4.74 (d, J ) 11.0, 1H), 4.77 (d, J ) 11.0, 1H),
4.95 (dd, J ) 8.0, 8.0, 1H) [Glu-2], 7.10-7.51 (m, 15H); 13C
NMR (CDCl3): δ 14.1, 16.7, 21.0, 22.6, 24.7, 25.0, 25.2, 26.3,
27.8, 29.1, 29.3, 29.6, 29.8, 29.9, 32.1, 33.8, 34.2, 34.7, 51.4,
68.2, 68.5, 73.4, 73.6, 74.6, 74.8, 75.3, 76.3, 78.0, 78.9, 79.4,
79.8, 83.0, 100.0, 100.4, 109.5, 127.4, 127.6, 127.7, 127.8, 128.2,
128.4, 138.1, 138.2, 138.3, 169.4, 174.2; negative-ion HRFAB-
MS m/z 945.5368 [M - H] (calcd for C55H77O13 m/z 945.5364).
Meth yl (11S)-11-[[(3,4,6-Tr i-O-ben zyl-â-D-glu cop yr a n o-
syl)-(1f2)-3,4-O-isop r op ylid en e-â-D-fu cop yr a n osyl]oxy]-
h exa d eca n oa te (8). Compound 7 (50 mg, 0.053 mmol) was
dissolved in anhydrous MeOH (1 mL), and a methanolic
sodium methoxide solution (8 mg of Na in 1 mL MeOH) was
added dropwise. The solution was stirred at rt under N2
atmosphere for 4 h. The reaction solution was diluted with
CH2Cl2, washed with cold 1 M HCl (10 mL), saturated solution
of NaHCO3 (2 × 10 mL), and water (1 × 10 mL), dried over
Na2SO4, and evaporated with a rotary evaporator. Purification
by chromatography on silica gel, eluting with 20% EtOAc in
hexanes, gave 45 mg (95%) of an oily product: IR (thin film)
3500, 1738 cm-1; [R]D -6.8 (c 3.5, CH2Cl2); 1H NMR (CDCl3) δ
0.88 (t, J ) 6.5, 3H) [J al-16], 1.22-1.40 (m, 20H), 1.34 (s, 3H),
1.37 (d, J ) 6.5, 3H) [Fuc-6], 1.46-1.53 (m, 2H), 1.53 (s, 3H),
1.60 (m, 2H), 2.28 (t, J ) 7.5, 2H) [J al-2], 3.65 (s, 3H), 3.59-
3.71 (m, 5H), 3.75-3.79 (m, 2H), 4.00 (brd, J ) 5.5, 1H) [Fuc-
J . Org. Chem, Vol. 69, No. 14, 2004 4569